ArticleBreast cancer research : BCR2025
Longitudinal changes in metabolism-related metrics and breast cancer risk: a general population study.
Article in Breast cancer research : BCR, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Association between serum chemerin and breast cancer mediated by lipid metabolism.Discover oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundMetabolism-related metrics have been widely investigated for their relationship with breast cancer risk but are mostly based on single values. Weight gain during adulthood has been related to an increased risk of breast cancer, while the relationship with changes in glucose and lipids remain largely unknown.
methodsWomen aged 20-80 were included from the general population-based Lifelines cohort when they had two assessments: 2007-2013 and 2014-2017. The following metrics were measured once at each of the two periods: body mass index (BMI), waist to height ratio (WHtR), hemoglobin A1c (HbA1c), HDL cholesterol (HDL-C), total cholesterol (TC), and triglyceride (TG). Women with a history of cancer, follow up less than 12 months, or who were pregnant during assessments were excluded. Mean annual changes (mean ACs) were calculated for each metric between the two periods, and further categorized into three groups - decrease, no change, and increase. Cox proportional hazards models were conducted to estimate their associations with breast cancer occurrence, reporting adjusted hazard ratios (aHR) with 95% confidence intervals (CI).
resultsDuring a median of 92.3 months follow-up, 1,202 of 58,785 women were diagnosed with breast cancer. Among women with a baseline BMI < 25 kg/m
conclusionsChanges over time in this real-world dataset from the general population highlight the benefits of weight loss and the harms of decreased glucose and TG in relation to breast cancer risk. These longitudinal patterns are affected by age, BMI, and initial values, emphasizing the importance of personalized metabolic health management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.